Posts tagged Teva

Teva weighs the most in eight weeks versus U. S. Court reverse the decision on patents

0

Teva Falls Most in 8 Weeks as U.S. Court Refuses to Overturn Patent Ruling
Teva Pharmaceutical Industries Ltd. declined the most in almost eight weeks after a U.S. Court denied a motion by the world’s largest maker of generic drugs to overturn a jury verdict on the validity of a Wyeth patent.

Read more on Bloomberg

Astra Zeneca grants Teva generic Crohn’s Drug License

0

AstraZeneca grants Teva generic Crohn’s drug license
LONDON (SHARECAST) – AstraZeneca has signed a deal with Teva Pharmaceuticals USA to settle patent litigation regarding Teva’s proposed generic version of Astra’s Entocort EC (budesonide) capsules used to treat Crohn’s disease.

Read more on ShareCast

Pfizer’s Wyeth wins trial over Teva copy of Protonix

0

Pfizer’s Wyeth wins trial over Teva copy of Protonix
WASHINGTON: Pfizer Inc’s Wyeth unit and Altana AG won a jury verdict on the validity of their patent for the heartburn drug Protonix, according to agencies report.

Read more on The Hindu

Teva expected to lose patent infringement suit to Pfizer

0

Teva expected to lose patent infringement suit to Pfizer
Teva Pharmaceutical’s business strategy in the United States is based largely on selling generic versions of blockbuster drugs even though the company is liable to lose patent infringement suits filed subsequently by the makers of the propriety versions.

Read more on Haaretz Daily

Teva shares fall after losing Protonix patent case

0

Teva shares fall after losing Protonix patent case
* Teva shares fall after Protonix patent ruling

Read more on Reuters via Yahoo! Philippines News

Pfizer wins Protonix patent case vs Teva

0

Pfizer wins Protonix patent case vs Teva
* Jury finds Protonix patent infringed by Teva

Read more on Reuters via Yahoo! Singapore News

Company Profile: Teva

0

Company Profile: Teva
As of 8:10 PM 04/16/10 All times are local (Market data is delayed by at least 15 minutes). Indexes reversed earlier losses after a big sell-off in Shanghai.

Read more on BusinessWeek

Go to Top